Adma Biologics reported $142.83M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US USD 142.83M 1.47M
Agile Therapeutics AGRX:US USD 1.43M 108K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Biocryst Pharmaceuticals BCRX:US USD 733.28M 19.63M
Dynavax Technologies DVAX:US USD 221.58M 275K
Novavax NVAX:US USD 549.78M 111.69M
Omeros OMER:US USD 442.44M 2.62M
Takeda 4502:JP JPY 4.29T 449.74B